Replengen Volume Dermal Filler
In fact, Replengen presents HA-based dermal filler of high purity obtained using cutting-edge technologies. However, a special technologies used in the production of Replengen Volume ensure also painless injection and maximal effect duration.
Benefits
- As well, it replenishes hydration.
- Besides, the removal of scars and stretch marks.
- Also, promotes the removal of nasolabial wrinkles.
- In addition, it creates and enhances a radiant glow.
- Moreover, it contributes to the removal of wrinkles around the eyes.
- Changing also the shape of the lips, increasing them to the desired size.
- And, face contouring (correction of the shape of the cheeks, cheekbones, chin).
- Delay even the appearance of fine lines and wrinkles, and promotes firmness and elasticity.
Warnings Of Usage:
Discontinue using this treatment if you are allergic to any of the ingredients. Consult even your dermatologist in case of any unusual side effects. Also, if you are pregnant or lactating then refrain from using . Also do not use if allergic to hyaluronic acid.
However, ingredients of this product are:
Hyaluronic Acid promotes skin hydration – keeps your skin moisturized and radiant. In addition, it has anti-wrinkle properties – due to its capacity to retain large amounts of water. So skin stays moisturized and helps to prevent the development of wrinkles, and fills in already present wrinkles to reduce their appearance.
Replengen Volume Dermal Filler (1×1.1ml)
Replengen Volume (1×1.1ml) is a Korean dermal filler based on cross-linked hyaluronic acid. This listing provides the product identity and package details for professional aesthetic product shoppers.
Use the package format and SKU to confirm the intended product, then review the listing for current price and availability. Browse the dermal fillers category to compare additional options.
- Product: Replengen Volume
- Category: Dermal filler
- Package format: 1×1.1ml
- SKU: 652311245968
Explore related options: Dermal Fillers



Reviews
There are no reviews yet.